Although the possible function of circulating VCAM-1 in the development of distant metastastic sites remains unknown, the findings suggest that evaluation of VCAM-1 levels in serum or biopsy specimens can be a novel marker for predicting a patient's risk of carcinoma metastasis and recurrence after surgery. Here, VCAM1 is linked to carcinoma.